Baker Bros. Advisors’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,643
Closed -$1.16M 106
2019
Q1
$1.16M Sell
3,643
-5,298
-59% -$2.3M 0.01% 88
2018
Q4
$10.9M Hold
8,941
0.09% 47
2018
Q3
$14.8M Hold
8,941
0.1% 48
2018
Q2
$15.8M Hold
8,941
0.12% 46
2018
Q1
$11.6M Hold
8,941
0.1% 53
2017
Q4
$7.22M Hold
8,941
0.06% 67
2017
Q3
$7.94M Buy
8,941
+3,884
+77% +$3.67M 0.06% 59
2017
Q2
$5.87M Hold
5,057
0.05% 61
2017
Q1
$7.28M Hold
5,057
0.06% 57
2016
Q4
$7.08M Hold
5,057
0.07% 57
2016
Q3
$10M Buy
+5,057
New +$9.93M 0.09% 55

Other funds holding CFRX

Baker Bros. Advisors's CFRX Position: Q2 2019 in Review

Baker Bros. Advisors sold out of ContraFect Corporation (CFRX) in Q2 2019, closing a stake of 3,643 shares — an estimated $1.16M sold.

Baker Bros. Advisors first reported a position in CFRX in Q3 2016 and held it in 11 quarters. The position peaked at $15.8M in Q2 2018. 40 funds tracked by Wall St. Rank hold CFRX as of Q2 2019.

  • Baker Bros. Advisors reported no remaining ContraFect Corporation position as of Q2 2019 after selling out during the quarter.
  • Baker Bros. Advisors sold 3,643 ContraFect Corporation shares in Q2 2019, an estimated $1.16M.
  • Baker Bros. Advisors first reported a position in ContraFect Corporation in Q3 2016 and held it in 11 quarters.
  • Baker Bros. Advisors's ContraFect Corporation position peaked at $15.8M in Q2 2018.
  • 40 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2019.

Based on Baker Bros. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.